Parkinson’s UK Sep 24 2024 Launching today, Landmark is a groundbreaking three-year research programme that aims to understand Parkinson’s in unprecedented detail. The project brings together Parkinson’s UK, Imperial College London, GSK, Novartis, Roche and UCB for the first time, and has been made possible by a founding gift of £4 million from the Gatsby charitable foundation.  Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK.

Tag-uri: Roche GSK